Works matching AU Lin-quan Tang

Results: 79
    1
    2
    3
    4
    5
    6
    7

    Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 3, p. 861, doi. 10.4143/crt.2017.237
    By:
    • Qiu-Yan Chen;
    • Shao-Yan Guo;
    • Lin-Quan Tang;
    • Tong-Yu Lu;
    • Bo-Lin Chen;
    • Qi-Yu Zhong;
    • Meng-Sha Zou;
    • Qing-Nan Tang;
    • Wen-Hui Chen;
    • Shan-Shan Guo;
    • Li-Ting Liu;
    • Yang Li;
    • Ling Guo;
    • Hao-Yuan Mo;
    • Rui Sun;
    • Dong-Hua Luo;
    • Chong Zhao;
    • Ka-Jia Cao;
    • Chao-Nan Qian;
    • Xiang Guo
    Publication type:
    Article
    8

    Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 3, p. 701, doi. 10.4143/crt.2017.180
    By:
    • Qiu-Yan Chen;
    • Qing-Nan Tang;
    • Lin-Quan Tang;
    • Wen-Hui Chen;
    • Shan-Shan Guo;
    • Li-Ting Liu;
    • Chao-Feng Li;
    • Yang Li;
    • Yu-Jing Liang;
    • Xue-Song Sun;
    • Ling Guo;
    • Hao-Yuan Mo;
    • Rui Sun;
    • Dong-Hua Luo;
    • Yu-Ying Fan;
    • Yan He;
    • Ming-Yuan Chen;
    • Ka-Jia Cao;
    • Chao-Nan Qian;
    • Xiang Guo
    Publication type:
    Article
    9
    10
    11

    Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928214
    By:
    • Liu, Li-Ting;
    • Liang, Yu-Jing;
    • Guo, Shan-Shan;
    • Mo, Hao-Yuan;
    • Guo, Ling;
    • Wen, Yue-Feng;
    • Xie, Hao-Jun;
    • Tang, Qing-Nan;
    • Sun, Xue-Song;
    • Liu, Sai-Lan;
    • Li, Xiao-Yun;
    • Yang, Jin-Hao;
    • Yang, Zhen-Chong;
    • Tang, Lin-Quan;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    12

    The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.

    Published in:
    BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02790-1
    By:
    • Tang, Lin-Quan;
    • Li, Xiao-Yun;
    • Li, Zhi-Ming;
    • Liu, Zhi-Gang;
    • Lin, Miao-Zhen;
    • Zhou, Huan;
    • Yu, Qi-Wen;
    • Zhou, Jian;
    • Zhao, Chong;
    • Chen, Ze-Bin;
    • Wang, Xi-Cheng;
    • Peng, Jia-Yu;
    • Chen, Qiu-Yan;
    • Fang, Wen-Feng;
    • Yang, Yun-Peng;
    • Zhang, Bei;
    • Xia, Liang-Ping;
    • Hu, Pi-Li;
    • Hu, Wei-Han;
    • Li, Yi-Jie
    Publication type:
    Article
    13
    14
    15
    16

    Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.

    Published in:
    Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5371, doi. 10.1007/s00520-021-06128-6
    By:
    • Duan, Yu-Yu;
    • Deng, Jun;
    • Su, Dong-Fang;
    • Li, Wen-Qiong;
    • Han, Yuan;
    • Li, Zhen-Xiu;
    • Huan, Xue-Zhen;
    • Zhu, Shi-Heng;
    • Yang, Qiu-Lan;
    • Hu, Wen;
    • Xin, Ming-Zhu;
    • Tang, Lin-Quan;
    • Mai, Hai-Qiang;
    • Fan, Yu-Ying;
    • He, Yan
    Publication type:
    Article
    17
    18

    Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 12, p. e2138470, doi. 10.1001/jamanetworkopen.2021.38470
    By:
    • Tang, Qing-Nan;
    • Liu, Li-Ting;
    • Qi, Bin;
    • Guo, Shan-Shan;
    • Luo, Dong-Hua;
    • Sun, Rui;
    • Sun, Xue-Song;
    • Chen, Dong-Ping;
    • Guo, Ling;
    • Mo, Hao-Yuan;
    • Wang, Pan;
    • Liu, Sai-Lan;
    • Liang, Yu-Jing;
    • Li, Xiao-Yun;
    • Yang, Zhen-Chong;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang;
    • Tang, Lin-Quan
    Publication type:
    Article
    19

    Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [<sup>18</sup>F]‐fluorodeoxyglucose positron emission tomography

    Published in:
    Cancer Medicine, 2020, v. 9, n. 23, p. 8852, doi. 10.1002/cam4.3500
    By:
    • Xie, Hao‐Jun;
    • Yu, Yi‐Fei;
    • Sun, Xue‐Song;
    • Jia, Guo‐Dong;
    • Luo, Dong‐Hua;
    • Sun, Rui;
    • Liu, Li‐Ting;
    • Guo, Shan‐Shan;
    • Liu, Sai‐Lan;
    • Chen, Qiu‐Yan;
    • Tang, Lin‐Quan;
    • Mai, Hai‐Qiang
    Publication type:
    Article
    20
    21
    22

    Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 9, p. 4214, doi. 10.1002/cam4.2343
    By:
    • Sun, Xue‐Song;
    • Chen, Wen‐Hui;
    • Liu, Sai‐Lan;
    • Liang, Yu‐Jing;
    • Chen, Qiu‐Yan;
    • Guo, Shan‐Shan;
    • Wen, Yue‐Feng;
    • Liu, Li‐Ting;
    • Xie, Hao‐Jun;
    • Tang, Qing‐Nan;
    • Li, Xiao‐Yun;
    • Yan, Jin‐Jie;
    • Mai, Hai‐Qiang;
    • Tang, Lin‐Quan
    Publication type:
    Article
    23
    24

    Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

    Published in:
    Medical Oncology, 2013, v. 30, n. 4, p. 1, doi. 10.1007/s12032-013-0685-6
    By:
    • Liu, Huai;
    • Huang, Pei-Yu;
    • Tang, Lin-Quan;
    • Chen, Qiu-Yan;
    • Zhang, Ying;
    • Zhang, Lu;
    • Guo, Ling;
    • Luo, Dong-Hua;
    • Mo, Hao-Yuan;
    • Xiang, Yan-Qun;
    • Qiu, Fang;
    • Sun, Rui;
    • Chen, Ming-Yuan;
    • Hua, Yi-Jun;
    • Lv, Xing;
    • Wang, Lin;
    • Zhao, Chong;
    • Guo, Xiang;
    • Cao, Ka-Jia;
    • Qian, Chao-Nan
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 8, p. 1294, doi. 10.1093/jnci/djae081
    By:
    • Lin, Da-Feng;
    • Li, Hai-Lin;
    • Liu, Ting;
    • Lv, Xiao-Fei;
    • Xie, Chuan-Miao;
    • Ou, Xiao-Min;
    • Guan, Jian;
    • Zhang, Ye;
    • Yan, Wen-Bin;
    • He, Mei-Lin;
    • Mao, Meng-Yuan;
    • Zhao, Xun;
    • Zhong, Lian-Zhen;
    • Chen, Wen-Hui;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang;
    • Peng, Rou-Jun;
    • Tian, Jie;
    • Tang, Lin-Quan;
    • Dong, Di
    Publication type:
    Article
    35

    Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

    Published in:
    OncoImmunology, 2015, v. 4, n. 2, p. N.PAG, doi. 10.4161/23723556.2014.976507
    By:
    • Zeng, Yi-Xin;
    • Li, Jiang;
    • He, Jia;
    • Li, Ze-Lei;
    • Tang, Xiao-Feng;
    • Chen, Shi-Ping;
    • Li, Yong-Qiang;
    • Huang, Li-Xi;
    • Ye, Shu-bio;
    • Ke, Miao-La;
    • Xia, Jian-Chuan;
    • Zhang, Xiao-Shi;
    • Zheng, Li-Min;
    • Chen, Qiu-Yan;
    • Tang, Lin-Quan;
    • Liu, Huai;
    • Zhang, Lu;
    • Guo, Shan-Shan;
    • Guo, Xiang;
    • Qian, Chao-Nan
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43

    Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40402-x
    By:
    • Yuan, Li;
    • Jia, Guo-Dong;
    • Lv, Xiao-Fei;
    • Xie, Si-Yi;
    • Guo, Shan-Shan;
    • Lin, Da-Feng;
    • Liu, Li-Ting;
    • Luo, Dong-Hua;
    • Li, Yi-Fu;
    • Deng, Shen-Wen;
    • Guo, Ling;
    • Zeng, Mu-Sheng;
    • Cai, Xiu-Yu;
    • Liu, Sai-Lan;
    • Sun, Xue-Song;
    • Li, Xiao-Yun;
    • Li, Su-Chen;
    • Chen, Qiu-Yan;
    • Tang, Lin-Quan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    44

    Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.

    Published in:
    EMBO Molecular Medicine, 2020, v. 12, n. 9, p. 1, doi. 10.15252/emmm.202012050
    By:
    • Li, Shi‐Bing;
    • Liu, Yan‐Yan;
    • Yuan, Li;
    • Ji, Ming‐Fang;
    • Zhang, Ao;
    • Li, Hui‐Yu;
    • Tang, Lin‐Quan;
    • Fang, Shuo‐Gui;
    • Zhang, Hua;
    • Xing, Shan;
    • Li, Man‐Zhi;
    • Zhong, Qian;
    • Lin, Shao‐Jun;
    • Liu, Wan‐Li;
    • Huang, Peng;
    • Zeng, Yi‐Xin;
    • Zheng, Yu‐Ming;
    • Ling, Zhi‐Qiang;
    • Sui, Jian‐Hua;
    • Zeng, Mu‐Sheng
    Publication type:
    Article
    45
    46
    47
    48
    49

    Relationship of circulating tumor cells and Epstein–Barr virus DNA to progression‐free survival and overall survival in metastatic nasopharyngeal carcinoma patients.

    Published in:
    International Journal of Cancer, 2019, v. 145, n. 10, p. 2873, doi. 10.1002/ijc.32380
    By:
    • You, Rui;
    • Liu, You‐Ping;
    • Lin, Mei;
    • Huang, Pei‐Yu;
    • Tang, Lin‐Quan;
    • Zhang, Yi‐Nuan;
    • Pan, Yi;
    • Liu, Wan‐Li;
    • Guo, Wei‐Bang;
    • Zou, Xiong;
    • Zhao, Ke‐Ming;
    • Kang, Ting;
    • Liu, Li‐Zhi;
    • Lin, Ai‐Hua;
    • Hong, Ming‐Huang;
    • Mai, Hai‐Qiang;
    • Zeng, Mu‐Sheng;
    • Chen, Ming‐Yuan
    Publication type:
    Article
    50